Search

everythinglearnresearchcommunity

for

Search:↓

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Thunbergia grandiflora and Russelia equisetiformis help each other grow by changing their shapes.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Ebastine may promote hair regrowth by increasing cell growth through the ERK pathway.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Wedelolactone may help treat chronic diseases due to its strong antioxidant properties.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

Oral etretinate improved hair length and reduced beading in monilethrix.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

CTP-543 is generally safe for treating alopecia areata.

Azathioprine caused side effects in over half of the Korean pediatric inflammatory bowel disease patients, requiring close monitoring.

The committee decided not to approve the drug due to low effectiveness and high risks.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Baricitinib is effective and safe for treating severe alopecia areata.

Switching from escitalopram to duloxetine improved hair loss.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.